We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMCB icon
11076
CALL
PharmaCyte Biotech
PMCB
$5.92M
$93K ﹤0.01%
38,600
+21,800
+130% +$55.1K
RPT
11077
CALL
Rithm Property Trust
RPT
$104M
$93K ﹤0.01%
+2,067
New +$119K
CBD
11078
PUT
DELISTED
Companhia Brasileira de Distribuicao
CBD
$93K ﹤0.01%
26,300
-2,100
-7% -$7.44K
LYLT
11079
CALL
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$93K ﹤0.01%
76,540
+36,640
+92% +$95.2K
ARCO icon
11080
CALL
Arcos Dorados Holdings
ARCO
$1.67B
$92K ﹤0.01%
+12,600
New +$90.7K
BITQ icon
11081
PUT
Bitwise Crypto Industry Innovators ETF
BITQ
$381M
$92K ﹤0.01%
14,300
-7,900
-36% -$59.4K
DLTH icon
11082
CALL
Duluth Holdings
DLTH
$153M
$92K ﹤0.01%
13,100
+2,200
+20% +$19.7K
GROY icon
11083
PUT
Gold Royalty Corp
GROY
$727M
$92K ﹤0.01%
36,100
-16,300
-31% -$43.7K
HTOO icon
11084
CALL
Fusion Fuel Green
HTOO
$16.8M
$92K ﹤0.01%
529
-1,148
-68% -$283K
MREO
11085
PUT
Mereo BioPharma
MREO
$50.9M
$92K ﹤0.01%
106,600
+10,700
+11% +$13.1K
NGL icon
11086
CALL
NGL Energy Partners
NGL
$2.24B
$92K ﹤0.01%
70,700
+13,300
+23% +$20.2K
VNET
11087
CALL
VNET Group
VNET
$2.16B
$92K ﹤0.01%
16,800
-1,300
-7% -$6.85K
SBDS
11088
CALL
DELISTED
Solo Brands Inc
SBDS
$92K ﹤0.01%
+603
New +$113K
HRTX icon
11089
PUT
Heron Therapeutics
HRTX
$63.9M
$91K ﹤0.01%
21,600
-1,600
-7% -$6.26K
MTA
11090
Metalla Royalty & Streaming
MTA
$912M
$91K ﹤0.01%
23,463
-31,804
-58% -$138K
VRCA icon
11091
PUT
Verrica Pharmaceuticals
VRCA
$85.4M
$91K ﹤0.01%
3,100
+1,480
+91% +$50.7K
UPH
11092
CALL
DELISTED
UpHealth, Inc.
UPH
$91K ﹤0.01%
17,190
-1,580
-8% -$9.44K
ABSI icon
11093
Absci
ABSI
$1.58B
$90K ﹤0.01%
28,848
-41,221
-59% -$151K
GLAD icon
11094
Gladstone Capital
GLAD
$446M
$90K ﹤0.01%
5,277
-22,811
-81% -$465K
HBM icon
11095
Hudbay
HBM
$11.9B
$90K ﹤0.01%
22,432
-1,422,025
-98% -$5.69M
JOF
11096
Japan Smaller Capitalization Fund
JOF
$355M
$90K ﹤0.01%
+15,371
New +$97K
LIND icon
11097
PUT
Lindblad Expeditions
LIND
$2.2B
$90K ﹤0.01%
+13,300
New +$116K
ABSI icon
11098
CALL
Absci
ABSI
$1.58B
$89K ﹤0.01%
+28,400
New +$104K
API
11099
PUT
Agora
API
$392M
$89K ﹤0.01%
+24,500
New +$116K
DAO
11100
CALL
Youdao
DAO
$2.17B
$89K ﹤0.01%
+22,600
New +$110K

Similar funds

Citadel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
  • Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.